Griffith University logo
Assoc Prof Emily Callander

Assoc Prof

Emily Callander

Associate Professor
School of Nursing and Midwifery
+61 (0)429 057 011 (Work)
+61 (0)7 3382 1788 (Work)
L05 3.11, Logan Campus

Are you Emily Callander?

Edit your profile


Associate Professor Callander is a Principal Research Fellow at Centre for Applied Health Economics, Griffith University. She specialises in efficiency and equity measurement using large population-based linked administrative datasets, and economic evaluations alongside clinical trials. She gained a PhD in Health Economics from the University of Sydney. She has worked as an economics academic since 2007 initially at Griffith University and the University of Sydney and has now returned to Griffith University. Associate Professor Callander has held continuous NHMRC funding throughout her career. She has previously held an NHMRC PhD Scholarship and NHMRC Early Career Fellowship (GNT1052742), and currently holds an NHMRC Career Development Fellowship (GNT1159536), and in 2017 was awarded a Queensland Young Tall Poppies Science Award. Associate Professor Callander has been involved in attracting over $12 million in competitive research funding, as either the lead investigator or lead health economist for her work. Dr Callander developed Australia's first models of patient costs and outcomes based on linked administrative data for mothers and babies. Along with members of the health economics team at the Charles Perkins Centre, University of Sydney, she has also undertaken internationally leading work on microsimulation modelling of the productivity impacts of ill health, which has been presented at the National Press Club, and annual presentations to the Commonwealth Treasury and Department of Health and Ageing. Pfizer UK and Pfizer Canada have also funded replications of this work. Her research on out of pocket expenditure in Australia has been directly cited by the Shadow Minister for Health to justify Federal Labor's campaign to overturn the Medicare rebate freeze, and consistently generated large amounts of media interest with articles in ABC Online, The Guardian, The Age, Sydney Morning Herald, Courier Mail, Money Magazine and Australian Financial Review. Associate Professor Callander is currently leading the health economics evaluation components of three large NHMRC Project Grant funded perinatal clinical trials, plus the health economic component of the NHMRC Centre for Research Excellence in Stillbirth (GNT1116640). As part of her involvement in these trials, she is integrating her research on inequality and indirect impacts of poor health into the health economic evaluation design. She works closely with leading health and medical research institutes across Australia including the NHMRC Clinical Trials Centre, Charles Perkins Centre, Mater Research Institute and the Menzies School of Health Research. CI Callander has had ongoing industry collaboration throughout her career - including working with Pfizer Australia to quantify the impact of chronic disease on income, tax and welfare payments, and to assess the impact of Lyrica® on labour force participation; Abbvie Pty Ltd to assess the economic impact of ankylosing spondylitis; National Seniors Australia and Illawarra Retirement Trust to assess the impact on increasing the retirement age to 70 on labour force participation; and the NSW Ministry of Health and Health Workforce Australia to conduct health workforce modelling. She is currently working with the Department of Health, Pharmaceutical Society of Australia and the National Aboriginal Community Controlled Health Organisation to evaluate a health workforce intervention. In total, she currently supervises 9 PhD students. Of her students, 70% have been awarded competitive research scholarships. She has previously supervised four Masters research students to completion. In 2018 she was awarded an Early Career Supervisor of the Year award. Associate Professor Callander has authored 90 peer-reviewed publications, plus 1 book chapter and 7 commissioned reports, despite career interruption due to maternity leave. These have been in highly regarded international journals such as Pediatrics, Nature Reviews Rheumatology, Arthritis and Rheumatology, British Journal of Psychiatry, Pain, and Health Economics.


  • Member
    EPIC Health Systems2019


  • Bachelor of Arts
    Griffith University2006 - 2008
  • Doctor of Philosophy
    University of Sydney2010 - 2013